Want to stay up to date?
Sign up for our newsletter
Board Room
“This is a great quest and we are proud to be a part of it. We owe it to our four legged friends, and at the same time, the technologies we are developing may also help cancer patients.” R. Scott Struthers, PhD, Crinetics Pharmaceuticals, Inc., Michelson Grant Recipient

Scientific Advisory Board

The Scientific Advisory Board of the Michelson Prize & Grants program is composed of world-class leaders from the scientific research and veterinary medical communities. Our advisors have an average of 30 years of relevant professional experience in areas such as reproductive biology, immunology, laboratory animal welfare, and regulatory affairs. The board provides valuable feedback to grant applicants at both the letter of intent and proposal stages.

Core Board

Todd Alonzo, PHD
Todd A. Alonzo, PhD
University of Southern California, Los Angeles, CA
Professor of Research, Department of Preventive Medicine,
Keck School of Medicine
Dr. Alonzo serves as the statistician for the Acute Myelogeneous Leukemia Strategy Group of the Children’s Oncology Group.

Show Bio

Dr. Alonzo completed his undergraduate degree in statistics at California State Polytechnic University, San Luis Obispo and his MS and PhD in biostatistics at the University of Washington. His research interests include development of statistical methods for analysis of biomarkers, medical diagnostic tests, and screening tests, design and analysis of clinical trials. He has published more than 125 peer-reviewed articles and two book chapters. Dr. Alonzo serves as the statistician for the Acute Myelogeneous Leukemia Strategy Group of the Children’s Oncology Group. He is a member of the Editorial Board for Pediatric Blood Cancer and Biometrical Journal and has served as a reviewer for 25 scientific journals. Dr. Alonzo is a member of a number of societies including the American Society of Clinical Oncology, the American Society of Clinical Oncology, the American Society of Hematology, the American Statistical Association, and the International Biometric Society. He currently resides in Glendora, CA with his wife (Kim), two boys (Peyton 13 and Carson 11), and Pets (Tahoe a 6-year old Labrador Retriever and Titan a 1-year old Maine Coon cat).

Janet Baer
Janet Baer, DVM
California Institute of Technology, Pasadena, CA
Director, Office of Laboratory Animal Resources

Dr. Baer has worked in multiple capacities in the field of laboratory animal medicine including as an on-call veterinarian for NASA and as an ad hoc site visitor for the Association for Assessment and Accreditation of Laboratory Animal Care.

Show Bio

Dr. Baer completed her undergraduate degree in Animal Behavior at the University of California, Davis and her MS in Veterinary Medicine and DVM at Washington State University. She is a Diplomate of the American College of Laboratory Animal Medicine. Dr. Baer currently serves as the Director of Laboratory Animal Resources at the California Institute of Technology. She also serves in the capacity of Attending Veterinarian for Children’s Hospital Los Angeles, Huntington Medical Research Institutes, the Heart Institute at Good Samaritan Hospital and Occidental College. Dr. Baer has worked in multiple capacities in the field of laboratory animal medicine including as an on-call veterinarian for NASA and serving as an AAALAC ad hoc site visitor for nine years. She has published a number of peer-reviewed articles on various aspects of laboratory animal medicine and was the first author of a book, Aotus: The Owl Monkey. She has also been the recipient of 3 NIH grant awards. She currently is an active member of three Institutional Biosafety Committees and serves on the Veterinary Medical Advisory Board for the Los Angeles Zoo. She resides in Pasadena, CA but spends portions of her summers in the Yellowstone National Park area.

Margaret Barr
Margaret C. Barr, DVM, PhD
Western University of Health Sciences, Pomona, CA
Professor of Virology & Immunology,
College of Veterinary Medicine

Dr. Barr is the project director for the Snow Leopard Functional Genomics Initiative and is investigating the immunogenetics of captive and wild snow leopards.

Show Bio

Dr. Barr received her DVM from Auburn University and her PhD from Cornell University. She is a Professor of Virology and Immunology and serves as Co-leader and facilitator for the Veterinary Basic Sciences problem-based learning (PBL) course at Western University of Health Sciences College of Veterinary Medicine. Dr. Barr is the project director for the Snow Leopard Functional Genomics Initiative and is investigating the immunogenetics of captive and wild snow leopards. Additional research projects include investigation of the molecular epidemiology of canine parvovirus and rickettsial agents in southern California. She serves on the board of directors for Pegasus Rising, an organization that provides equine-assisted therapy to veterans with PTSD and traumatic brain injuries.

David Brake
David A. Brake, PhD
BioQuest Associates, LLC, East Lyme, CT
Founder and Principal

Dr. Brake is a scientific consultant to the U.S. Department of Homeland Security Science and Technology, providing technical and project management expertise for several transboundary animal and zootic disease vaccine and diagnostic projects.

Show Bio

Dr. Brake completed his BS in Biology at Muhlenberg College. After completing a PhD in Microbiology and Immunology at Hahnemann Medical University (now Drexel College of Medicine), he completed a 3-year NIH post-doctoral fellowship at SmithKline Beecham Pharmaceuticals in the field of HIV molecular genetics. He was employed as a research immunologist at SmithKline Beecham Animal Health for 5 years, followed by 8 years at Pfizer Animal Health where he held several scientific and management positions in Veterinary Medicine Biological Discovery and Biological Development. During his private industry tenure, Dr. Brake worked on numerous new vaccines for companion animals, livestock, and poultry and published scientific papers in the areas of veterinary immunology, immunoparasitology, and vaccinology. In 2004, he founded the vaccine consulting company, BioQuest Associates, LLC. Dr. Brake currently serves as a scientific consultant to the U.S. Department of Homeland Security Science and Technology, providing technical and project management expertise for several transboundary animal and zootic disease vaccine and diagnostic projects. Dr. Brake also provides consultancy services to clients in the biotechnology and biopharmaceutical industries. He enjoys running and reading, and resides in East Lyme, CT with his spouse and affectionate cat, Bruno.

Thomas J. Conlon, PhD
Thomas J. Conlon, PhD
University of Florida, Gainesville, FL
Associate Professor in Pediatrics
Director, Powell Gene Therapy Center Toxicology Core

Dr. Conlon is the Director of the Powell Gene Therapy Center Toxicology Core at the University of Florida, where he is an expert in recombinant adeno-associated virus (rAAV) vectors.

Show Bio

Dr. Conlon completed his undergraduate degree in genetics at Texas A&M University and his PhD in genetics/biomedical studies at the University of Florida. As the Director of the Powell Gene Therapy Center Toxicology Core, Dr. Conlon facilitates efficient, cost-effective, and rigorous preclinical testing of gene therapy vectors, with a special emphasis on recombinant adeno-associated virus (rAAV) vectors. Dr. Conlon has brought 11 gene therapy trials through the FDA, including the active gene therapy trial for glycogen storage disease (GSD) II. Dr. Conlon has been at the forefront of collaborations between the PGTC, the University of Florida College of Medicine’s Department of Pediatrics, and the University of Florida College of Veterinary Medicine to identify means for treating congestive heart failure and GSD in people, as well as two types of cardiac problems experienced in dogs. Dr. Conlon was a 2014 recipient of the “See the Lights” award from the The Mathew Forbes Romer Foundation for excellence in the fight against children’s genetic diseases and is currently the Membership Chair of the American Society of Gene and Cell Therapies.

Marcelo Couto
Marcelo A. Couto, DVM, PhD, DACLAM
University of California, Los Angeles, CA
Associate Professor, Pathology and Laboratory Medicine, David Geffen School of Medicine

Among Dr. Couto’s achievements are creating and directing UCLA’s Assisted Reproductive Technologies lab and creating a computer-based system for reporting veterinary clinical health cases.

Show Bio

Dr. Couto completed his veterinary degree at the University of Buenos Aires, Argentina, his Residency in Veterinary Reproduction, and his PhD in Comparative Pathology at the University of California, Davis. He pursued postdoctoral training in Molecular and Cell Immunology at the University of California, Los Angeles. Dr. Couto is Board Certified by the American College of Laboratory Animal Medicine and has worked in the laboratory animal field for over 22 years. He has held professional positions at Guidant Corporation, the Scripps Research Institute, the University of California, Davis, and more recently as Executive Director and Chair of the Division of Laboratory Animal Medicine at UCLA.

Thomas Graves
Thomas K. Graves, DVM, PhD, DACVIM
Midwestern University, Glendale, AZ
Dean, College of Veterinary Medicine

Dr. Graves is a veterinary educator and endocrinologist, focusing on geriatric medicine and diabetes.

Show Bio

Dr. Graves completed his DVM degree at Cornell University and his MS and PhD in Pharmacology at the University of Rochester School of Medicine. He completed a small animal internship at the Ohio State University and a small animal internal medicine residency at Michigan State University. Dr. Graves is a Diplomate of the American College of Veterinary Internal Medicine and past Chair of the Scientific Advisory Board for the Morris Animal Foundation. He currently serves on the organization’s Animal Welfare Assurance Committee. He has published and spoken extensively in the area of small animal endocrinology. His research, focusing on geriatric medicine and diabetes, has been funded by the American Association of Feline Practitioners, the American Animal Hospital Association, the Feline Winn Foundation, and the National Institutes of Health.

Carl Johnson
Carl D. Johnson, PhD
Hereditary Disease Foundation, New York, NY
Executive Director for Science Emeritus

Dr. Johnson is an accomplished biochemist, geneticist, and neurobiologist with experience both in biotech and pharmaceutical industries and in medical research foundations.

Show Bio

Dr. Johnson received his BS in Chemistry from the University of Chicago and a PhD in Biology from the California Institute of Technology. He performed postdoctoral research in Neurochemistry and Neuroanatomy at the University of Wisconsin. In 1986, Dr. Johnson joined Cambridge NeuroScience, Inc. as Director of Genetics. In 1990, he co-founded NemaPharm, Inc., the first company to focus on using a genetically tractable model animal, the nematode Caenorhabditis elegans, for studies designed to identify human therapeutics. Dr. Johnson joined the Hereditary Disease Foundation (HDF) as Executive Director of the ‘Cure Huntington’s Disease Initiative’ in 2001. In 2004, Dr. Johnson became Executive Director for Science of the HDF, managing all aspects of the Foundation’s scientific programs. He retired from that position in 2016. Dr. Johnson consults and reviews grant applications for the Found Animals Foundation and other groups. He lives in Madison, Wisconsin with wife Susan Curtis, adopted cats Lena and Sammy, and two rescued Blue Heelers, Mabel and Boss.

Kevin N. Morris, PhD
Institute for Human-Animal Connection, University of Denver, Denver, CO
Associate Research Professor

Dr. Morris has been actively involved in cancer research in both academic and biotechnology environments for over 20 years.

Show Bio

Dr. Morris is an Associate Research Professor in the Institute for Human-Animal Connection at the University of Denver. He holds a PhD in Molecular Biology and Biochemistry from the University of Chicago. After 20 years of preclinical and clinical cancer research, he began focusing his scientific skills on the advancement of animal health and welfare and a better understanding of the impacts of animals on humans through research and analysis; first as the Director of Research at the Animal Assistance Foundation and now as a faculty member at the Institute for Human-Animal Connection. He serves as the Principal Investigator on a wide range of studies aimed at defining the effects of therapy animals in a variety of environments and the impacts of companion animals on human health. He has served on the Board of Directors of the Alliance for Contraception in Cats and Dogs since 2011.

Linda Rhodes
Linda Rhodes, VMD, PhD
Aratana Therapeutics, Inc., Kansas City, KS
Chief Scientific Officer (Ret.)

Dr. Rhodes has 28 years of accomplishments in human and animal drug discovery, development, biomedical research, and clinical veterinary medicine.

Show Bio

Dr. Rhodes was educated at the University of Pennsylvania School of Veterinary Medicine (VMD) and Cornell University (PhD). She has 28 years of accomplishments in human and animal drug discovery, development, biomedical research, and clinical veterinary medicine. She has an extensive background in physiology, veterinary medicine, and molecular biology. As a senior research fellow at Merck Research Laboratories for 10 years, she led pre-clinical biology evaluation of several marketed human drugs. Dr. Rhodes practiced clinical veterinary medicine for five years, with experience in both companion and farm animal practice. She worked for Merial Ltd. as director of development projects, leading project teams developing novel compounds for a variety of indications and headed new technology assessment, leading the evaluation of licensing opportunities. In April 2001, she formed AlcheraBio, a consulting, marketing, communications, and contract research firm specializing in developing new drugs for animals, working with biotechnology and animal health companies, with clients in the US, European Union, Canada, and Australia. AlcheraBio was acquired in 2008 by Argenta, and in 2011, Dr. Rhodes accepted a position as CEO of Aratana Therapeutics, a venture capital backed start up company developing innovative new medicines for dogs and cats, and subsequently, when the company became public (PETX) served as its Chief Scientific Officer. She is currently retired and an independent consultant. She is a member of the Board of Directors of ImmuCell and the Alliance for Contraception in Cats and Dogs, and she serves as an adjunct faculty member in the Graduate Animal Science program at Rutgers University.

Amy A. Ross, PhD
Amy A. Ross, PhD
University of Southern California, Los Angeles, CA
Trustee

Dr. Ross received her PhD in Experimental Pathology and has more than 25 years of experience in the bone marrow transplantation/cancer diagnostic field.

Show Bio

Dr. Ross received her PhD in Experimental Pathology from USC in 1986. She worked in biotechnology and the bone marrow transplantation/cancer diagnostics field for over 25 years. Her research focused on the detection of low numbers of tumor cells in the circulation of breast cancer patients as a means of targeting early relapse. She is the author of over 75 scientific publications and the holder of three US patents. Although most of Dr. Ross’ career was in the biotechnology industry, she spent three years developing a tissue culture system for bone marrow-derived stem cells in the laboratory of Dr. Ellen Rothenberg at Caltech. An active USC alumna, Dr. Ross was a co-founder of the USC LGBT Alumni Association and is currently a member of the USC Board of Trustees.

Josep Rutllant
Josep Rutllant, DVM, PhD
Western University of Health Sciences, Pomona, CA
Professor, Anatomy and Embryology,
College of Veterinary Medicine

Dr. Rutllant is a veterinary anatomist with research interests in gamete physiology, and a recipient of the Norden-Pfizer Award for Distinguished Teaching of Veterinary Medicine.

Show Bio

Dr. Rutllant received his DVM and PhD (Veterinary Medicine) from the School of Veterinary Medicine, Autonomous University of Barcelona. He completed a NATO Postdoctoral Fellowship at the Center for Animal Transgenesis and Germ Cell Research, University of Pennsylvania School of Veterinary Medicine, and has held positions of lecturer and visiting professor of veterinary anatomy at the University of California, Davis. Dr. Rutllant’s research funding and publications are in the general areas of sperm cell biology and function, to include isolation of spermatogonial stem cells and Sertoli cells from dogs, patterns of MHC protein expression during porcine spermatogenesis, and expression and characterization of aquaporin water channels in equine sperm. He is a recipient of the Norden-Pfizer Award for Distinguished Teaching of Veterinary Medicine, and the Pfizer Award for Research Excellence at the WesternU CVM.

William Swanson
William F. Swanson, DVM, PhD
Cincinnati Zoo and Botanical Garden, Cincinnati, OH
Director, Animal Research, Center for Conservation
and Research of Endangered Wildlife

Dr. Swanson currently leads a multi-disciplinary research team at the Cincinnati Zoo with a primary focus on maternal and embryonic factors affecting reproductive success in small felids.

Show Bio

Dr. Swanson was educated at the University of Texas, Austin (BS), Texas A&M University (DVM), and Louisiana State University (PhD, Animal Science). He currently leads a multi-disciplinary research team at the Cincinnati Zoo on the preservation of endangered animal species, with a primary focus on maternal and embryonic factors affecting reproductive success in felids. He participates in collaborative studies of endangered small felids in Mongolia, Thailand, South Africa, the UAE, and Brazil, and he trains foreign scientists in conservation strategies. He was Co-Chair of the Felid Taxon Advisory Group of the Association of Zoos and Aquariums for ten years and has published and spoken widely on reproductive physiology of endangered and domestic felids. Before joining the Cincinnati Zoo, Dr. Swanson completed a postdoctoral fellowship in reproductive physiology of domestic and nondomestic felids, and worked as a gamete biologist at the Conservation & Research Center, Smithsonian National Zoological Park, in Front Royal, VA. He received a five-year Special Emphasis Research Career Award from the National Center for Research Resources of the NIH. Work at the Smithsonian included examination of maternal and embryonic factors affecting reproductive success in felids. Specific studies were directed toward the application of in vitro fertilization and embryo transfer for propagation of felid models of human disease and for conservation of endangered cat species.

John Tegzes
John H. Tegzes, MA, VMD, DABVT
Western University of Health Sciences, Pomona, CA
Professor, Toxicology, College of Veterinary Medicine

Dr. Tegzes is a nurse and a veterinary toxicologist with expertise in interdisciplinary education.

Show Bio

Dr. Tegzes was educated at Thomas Jefferson University (BS Nursing), University of Santa Monica (MA Applied Psychology) and University of Pennsylvania (VMD). He is a Diplomate of the American Board of Veterinary Toxicology and a recipient of the Norden Award for Distinguished Teaching of Veterinary Medicine. His career has included professional positions in nursing practice, veterinary practice, completion of a residency in veterinary toxicology at the University of California, Davis, and veterinary outreach through PeaceWorks in Honduras. At Western University, he directed the first year, Problem-Based learning curriculum at the College of Veterinary Medicine, serves as the faculty content resource in toxicology, and is a member of the Interprofessional Education Committee.

Marcel van Duin, PhD
Marcel van Duin, PhD
Ferring Research Institute, San Diego, CA
Senior Director, Therapeutic Area Head Reproductive Health Research

Dr. van Duin has more than 25 years experience in the pharmaceuticals and reproductive health industries.

Show Bio

Marcel van Duin received his PhD from the Erasmus University in Rotterdam after which he started his scientific career in pharmaceutical research at Organon in Oss, The Netherlands, where he worked on immunological approaches to fertility control as well as the discovery of novel targets for the development of new methods for female and male fertility control. In 2001, he moved to Organon Research in Newhouse, Scotland, to become the Head of Target Discovery in cardiovascular and neuroscience therapeutic programs. In early 2003, he returned to the Netherlands to accept the position of Head of Pharmacology at Organon. In this position, he was responsible for all pharmacological research in the areas of reproductive biology, oncology and immunology, the in vitro ADME and early toxicology group, as well as the animal research facilities. Following Organon’s acquisition by Schering Plough in 2007, he joined the Research Leadership Team of Schering-Plough as VP and Therapeutic Area Head Women’s Health. In Oss, the Netherlands, he became the head of the Women’s Health department with research programs in male and female contraception, infertility, endometriosis and menopausal symptoms. Following the merger with Merck in 2009, he was appointed as VP and Worldwide Discovery Head for the Women’s Health and Endocrine franchise with responsibility for the global discovery activities in this therapeutic area.

Due to the closing of the former Organon Research site in Oss, Dr. van Duin left the Merck organization early in 2012 and established his own independent consulting company. He has been advising on the scientific merits of a variety of pharma R&D projects and has facilitated valorization plans and strategies for academic research programs. As of March 1, 2014, he has joined the Ferring Pharmaceuticals organization in which he is now responsible for Ferring’s Reproductive Health Research. He has 25+ years of experience in various successful leadership positions in the pharma industry.

David Wildt
David E. Wildt, PhD
Smithsonian National Zoological Park, Front Royal, VA
Senior Scientist and Head, Center for Species Survival

Dr. Wildt manages the wildlife animal collection at the National Zoo’s 3,200-acre Smithsonian Conservation Biology Institute, a living laboratory in Virginia.

Show Bio

Dr. Wildt has conducted research at Michigan State University, Baylor College of Medicine, Texas A&M University, the National Institutes of Health, and now the Smithsonian’s Conservation Biology Institute. He leads a group of scientists, fellows, students and technicians who study the biology of animals, from the domestic cat and dog to frogs and elephants. Dr. Wildt also manages the wildlife animal collection at the National Zoo’s 3,200-acre Smithsonian Conservation Biology Institute, a living laboratory in Virginia. Basic and applied research is devoted to creating scholarly knowledge that leads to better management and conservation of small populations, especially of endangered species. Efforts are centered on reproduction, but also are linked to genetics, veterinary medicine, behavior, nutrition, ecology, small population biology and the reintroduction of species to nature. This cross-disciplinary integration is fundamental to Dr. Wildt’s philosophy and his team’s research on the cheetah, Florida panther, black-footed ferret, and the giant panda, among others. Besides a text edited by Dr. Wildt and his colleagues, Giant Pandas: Biology, Veterinary Medicine and Management (Cambridge University Press), he has more than 285 publications in the peer-reviewed literature and 57 book chapters spanning more than 50 vertebrate species.

Joanne Zahorsky-Reeves
Joanne Zahorsky-Reeves, DVM, PhD
University of California, Los Angeles, CA
Regulatory Affairs Program Administrator,
Division of Laboratory Animal Medicine,
David Geffen School of Medicine

Dr. Zahorsky-Reeves worked in xenotransplantation genetics at USC and Childrens Hospital LA, and now is a laboratory animal veterinarian at UCLA.

Show Bio

Dr. Zahorsky-Reeves attended Cornell University both undergraduate (BS with Honors ‘90) and veterinary school (’95). She completed her PhD in Comparative and Experimental Medicine at the University of Tennessee School of Veterinary Medicine, Knoxville (’99). She worked as a post-doc in xenotransplantation genetics at the University of Southern California and Childrens Hospital Los Angeles (’99-’04). Dr. Zahorsky-Reeves now serves as the laboratory animal veterinarian in the Division of Laboratory Animal Medicine at the David Geffen School of Medicine, UCLA, and is board certified in lab animal medicine (DACLAM) (’11).

Aimee Gilbreath
Aimee Gilbreath, MBA
Ex Officio Member
Found Animals, Los Angeles, CA
Executive Director

Ms. Gilbreath is responsible for the development and launch of all major programs including the $75M Michelson Prize & Grants program, pet adoption programs that place nearly 5,000 shelter animals per year, and a free, nationwide online microchip registry.

Show Bio

Aimee was born with a love of animals, which eventually led to her position as Found Animals’ Executive Director. In her role as head of the social entrepreneurship and innovation focused non-profit in the pet space, Aimee is responsible for the development and launch of all major programs including the $75M Michelson Prize & Grants program, pet adoption programs that place nearly 5,000 shelter animals per year, and a free, nationwide online microchip registry. She also serves as a Board Member for Spay4LA and the Spay Neuter Project of Los Angeles, which together have four clinics that provide over 30,000 subsidized surgeries to underserved communities each year.

Before Aimee joined Found Animals as its first employee in March 2008, she earned her MBA from Stanford University and rose to Principal at The Boston Consulting Group (BCG), a management strategy consulting firm that works with Fortune 500 companies to solve complex business issues. During this time, in an effort to introduce balance and service into her busy business career, Aimee began volunteering for a local animal rescue group. It was here Aimee fell in love with one of the most popular yet misunderstood breeds of dog, the pit bull. She eventually adopted a pit bull of her own – Rufus — who accompanies Aimee to the Found Animals’ office daily.

Earlier in her life Aimee received a full scholarship to attend the University of Arizona, where she earned her B.S. in Molecular and Cellular Biology, graduating summa cum laude in 1996. She began her career in biotechnology and was hired by Motorola Corporation’s R&D division. Aimee was the third member of a team recruited to start a biotechnology research program with the goal to develop a biochip device for use in personalized medicine.

Ad Hoc Board

Lawrence G. Carbone, DVM, PhD, DACLAM
University of California, San Francisco, CA
Associate Director, Laboratory Animal Resource Center
Rebecca L. Davies, PhD
University of Minnesota, St. Paul, MN
Director, Quality Central Quality Assurance Program
Associate Clinical Professor, Veterinary Diagnostic Laboratory, College of Veterinary Medicine
Amy E. Fischer, PhD
University of Illinois, Urbana, IL
Teaching Associate & Extension Specialist,
Department of Animal Sciences
Herod L. Howard, DVM, MPVM, DACLAM
The Scripps Research Institute, La Jolla, CA
Senior Director, Institutional Animal Program
Safdar A. Khan, DVM, MS, PhD, DABVT
American Society for the Prevention of Cruelty to Animals,
Urbana, IL
Director of Toxicology, Animal Poison Control Center
David M. Petrick, VMD, JD
Delta Consortium Regulatory Consulting, Ltd, Princeton, NJ
Principal
Margaret V. Root Kustritz, DVM, PhD, DACT
University of Minnesota, St. Paul, MN
Professor, Small Animal Reproduction,
College of Veterinary Medicine
Andrew N. Rowan, PhD
Humane Society of the United States, Washington, DC
Chief International Officer & Chief Scientific Officer
President & CEO, Humane Society International
President, Humane Society University
Margaret R. Slater, DVM, PhD
ASPCA, Northampton, MA
Senior Director, Veterinary Epidemiology,
Shelter Research and Development
Nancy S. Wexler, PhD
Hereditary Disease Foundation, New York, NY
President
Professor, Departments of Neurology and Psychiatry,
Columbia University
Stephen Zawistowski, PhD, CAAB
ASPCA, New York, NY
Science Advisor Emeritus